BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/9/2022 12:48:14 PM | Browse: 385 | Download: 1114
 |
Received |
|
2022-03-20 08:10 |
|
Peer-Review Started |
|
2022-03-20 08:12 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-04-17 03:10 |
|
Revised |
|
2022-05-09 19:16 |
|
Second Decision |
|
2022-07-29 02:49 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-08-01 04:37 |
|
Articles in Press |
|
2022-08-01 04:37 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-07-26 04:32 |
|
Typeset the Manuscript |
|
2022-08-26 01:38 |
|
Publish the Manuscript Online |
|
2022-09-09 12:48 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Implication of gut microbiome in immunotherapy for colorectal cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Nikolaos Papadopoulos, Georgios Aloizos, Ariadne Tsagarakis, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Athanasios G Papavassiliou and Michalis V Karamouzis |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Evangelos Koustas, MD, PhD, Doctor, Doctor, Senior Research Fellow, Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 75 M. Asias Street, Athens 11527, Greece. vang.koustas@gmail.com |
| Key Words |
Colorectal cancer; Gut microbiome; Immunotherapy; Checkpoint inhibitors; Tumor microenvironment |
| Core Tip |
Colorectal cancer constitutes the third most frequent malignancy. CRC is a complex, multistep process. The impact of environmental factors, as well as the disturbance of the gut microbial ecosystem, is associated with CRC development. There is a strong relationship between the gut microbiome and resistance to immunotherapy. |
| Publish Date |
2022-09-09 12:48 |
| Citation |
Koustas E, Trifylli EM, Sarantis P, Papadopoulos N, Aloizos G, Tsagarakis A, Damaskos C, Garmpis N, Garmpi A, Papavassiliou AG, Karamouzis MV. Implication of gut microbiome in immunotherapy for colorectal cancer. World J Gastrointest Oncol 2022; 14(9): 1665-1674 |
| URL |
https://www.wjgnet.com/1948-5204/full/v14/i9/1665.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v14.i9.1665 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
